We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
A new world is possible. Let's not go back to what wasn't working anyway.
Add this topic to your myFT Digest for news straight to your inbox
Scientists ‘disappointed’ by deferral of pledge to invest £22bn annually in R&D by 2024-25
Move contrasts with mRNA makers Pfizer and Moderna, which have rejected sharing vaccine technology
Data from drugmaker and US regulator suggest advantages of Covid-19 jab would far outweigh risks
Shift in Whitehall mood as latest data show week-on-week decline in coronavirus cases
British politicians have a strained relationship with the discipline, but funding it is the path to better, more highly-skilled jobs
Launch of commercial station to be called Orbital Reef eyed for latter half of this decade
Biden administration outlines requirements as it prepares to ease travel restrictions from November 8
Researchers emphasise that adverse events following Pfizer and AstraZeneca jabs are extremely rare
Ministers have committed to end new transmissions of HIV by 2030 — but they must commit to fully funding the means
Financial lobby group that includes Goldman Sachs says ‘talent’ is deserting the territory
The COP26 delegates would do well to look at the world from the perspective of animals
Infection and death rates are the world’s highest and vaccination take-up is low, forcing renewed restrictions
Concern over booster campaign as advisers urge government to prepare for ‘rapid deployment’ of tighter Covid restrictions
US regulatory shake-up will mainly effect people who would otherwise have gone without
Their odours send signals about marauding insects or changing soil conditions, but also connect with human culture and memory
Asia-Pacific countries ease restrictions on passengers vaccinated against Covid-19
Science and industry leaders warn on 2024-5 backtracking in Budget spending review
Ministers weigh fresh restrictions as medics juggle flu cases with rise in emergency demand and patient backlog
Results hailed as ‘important’ but duration of protection still unknown
British Medical Association claims UK government is being ‘wilfully negligent’ in refusing to act
Narendra Modi celebrates ‘triumph of Indian science’ months after devastating second wave
Health secretary urges people to get booster jabs to avoid fresh restrictions
Russian workplaces to shut down from October 30 amid rising case numbers and deaths
Demand comes as daily death toll hits highest level since March and hospitalisations near 1,000
Suggestion ex-secretary of state would have benefited from treatment dismissed as ‘highly speculative’
International Edition
